Old Web
English
Sign In
Acemap
>
authorDetail
>
Kim Aardalen
Kim Aardalen
Chiron Corporation
Cancer research
Apoptosis
Cytotoxicity
Mechanism of action
Prodrug
4
Papers
134
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons In vitro and In vivo
2007
Clinical Cancer Research
Archie N. Tse
Katherine Rendahl
Tahir Sheikh
Haider Cheema
Kim Aardalen
Millicent Embry
Sylvia Ma
E.J. Moler
Zhi Jie Ni
Daniel Menezes
Barbara Hibner
Thomas G. Gesner
Gary K. Schwartz
Show All
Source
Cite
Save
Citations (121)
Tezacitabine enhances the DNA-directed effects of fluoropyrimidines in human colon cancer cells and tumor xenografts
2007
Biochemical Pharmacology
Pietro Taverna
Katherine Rendahl
Dragana Jekic-Mcmullen
Yi Shao
Kim Aardalen
Fernando Salangsang
Laura V. Doyle
Eddie Moler
Barbara Hibner
Show All
Source
Cite
Save
Citations (11)
Biomarqueurs de modulation cible, efficacité, diagnostic et/ou pronostic pour les inhibiteurs de la raf
2007
Natasha Aziz
E.J. Moler
Darrin Stuart
Carla Heise
Kim Aardalen
Show All
Source
Cite
Save
Citations (0)
1